Pharmacoeconomic Evaluation of Antidiabetic Medication in Geriatric Type 2 Diabetes- A Brief Study
No Thumbnail Available
Date
2024-12
Journal Title
Journal ISSN
Volume Title
Publisher
?Eldaghayes Publisher
Abstract
Introduction: Diabetes mellitus (DM) is a long-term condition that poses an enormous health and economic burden on society. Unfortunately, there is a dearth of such evidence in India. Hence, we sought to estimate the direct cost of antidiabetic medication in the geriatric population. Aim and Objectives: The aim of this study is to evaluate the pharmacoeconomic of antidiabetic medication in geriat- ric type 2 diabetes mellitus patients attending outpatient department in a tertiary care teaching hospital. Materials and Methods: The demographic characteristics, clinical characteristics, and treatment profiles of patients were compiled. All diabetic patients who visited an outpatient department had their prescriptions recorded. A pharma- coeconomic analysis of prescribed anti-diabetic medications was conducted. Results: The study enrolled 600 DM patients, of which 67.83% were males, 32.17 % were females, and the pre- dominant age group was 60–64 years. In 94.54% of patients, the most frequently prescribed antidiabetic drug was metformin 500 mg. In 39.31% of patients, the most frequently prescribed antidiabetic combination was glimepiride 2 mg + metformin 500 mg. Insulin was prescribed in 14.83% of the cases. The percentage cost difference for diabetes medications ranges from 43.010 to 644.444. The monthly cost of monotherapy for most patients with controlled diabe- tes (31.46%) and uncontrolled diabetes (42.12%) was between 500 and 1000 INR. In addition, the cost of combination therapy ranges between INR 118.91 and INR 300.27. Conclusion: The costs associated with diabetes are immense and impose a substantial burden on society. Consequent- ly, policymakers should prioritize preventing the disease and its associated problems.
Description
Keywords
Pharmacoeconomic, Drug utilization, Antidiabetic drug, Diabetes mellitus, Glimepiride, Metformin
Citation
Jakhar A, Hussain S, Hussain MS, Saifi L, Usman K, Sawlani KK, Khattri S.. Pharmacoeconomic Evaluation of Antidiabetic Medication in Geriatric Type 2 Diabetes- A Brief Study . National Journal of Physiology, Pharmacy and Pharmacology. 2024 Dec; 14(12): 2617-2626